Clinical trial · Interventional
Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
NCT01938339CI-TRIAL-00012894unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To development of clinical assessment technique using multi-radiotracer positron emission tomography/magnetic resonance (PET/MR) in prostate cancer * to establish the optimal imaging technique of PET/MR using multiple radioactive tracers for prostate cancer * to establish the imaging biomarker using PET/MR for clinical assessment of prostate cancer and early detection of recurrent prostate cancer
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer Recurrent | — | UNRESOLVED | — |
| Stage III Prostate Carcinoma | Prostate Carcinoma | CURATED_BROADER | 0.78 |
| Stage II Prostate Carcinoma | Prostate Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET/MR | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- PET/MR
- description
- Multi-radiotracer PET/MR will be performed to compare the accuracy of tumor detection in patient with primary prostate cancer
- interventionNames
- Device: PET/MR
Primary outcomes (1)
- measure
- accuracy of PET/MR predicting localization and staging of prostate cancer
- timeFrame
- 1 week after radical prostatectomy
- description
- analysis of accuracy of PET/MR predicting localization and staging of prostate cancer by comparison of PET/MR findings with pathological mapping images after radical prostatectomy
Secondary outcomes (1)
- measure
- accuracy of early detection and localization of recurrent prostate cancer
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * patient with prostate cancer before treatment * patient with prostate cancer treated * patient with prostate cancer recurrent Exclusion Criteria: * patient with contraindication for MRI * Patient with severe renal impairment
References
Publications (0)
Data not yet available
No reference posted for this study.